The new coronavirus known as SARS-CoV-2, due to its similarity to the previous SARS, was detected for the first time in December 2019 in Wuhan City, China. It is characterized by causing, in most patients, nonspecific symptoms similar to those of a common flu. It has been reported that many of COVID-19 patients presented neurological symptoms that involve the central (CNS) and the peripheral nervous system (PNS). There have been several reports of patients who presented Guillain‐Barré Syndrome (GBS) related to COVID-19 infection, with sensory and motor compromise in the extremities. In this work, we will describe a case of GBS, with bilateral facial palsy, as the only manifestation of the neurological compromise following SARS-Cov-2 infection. We will include a complete neurophysiological study and discusse some pathophysiological mechanisms.
Covid 19, SARS Cov 2, Gullan Barre Syndrome, Facial Palsy.
Commitments / Obligations
Publicación de un artículo indexado
|Paralisis facial por SARS Cov 2
|Effective start/end date
|11/1/20 → 5/1/21
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
Main Funding Source
- Competitive Funds
- Bogotá D.C.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.